The Prevalence and Management of Diabetic Nephropathy in Asia
about
Lovastatin Alleviates Endothelial-to-Mesenchymal Transition in Glomeruli via Suppression of Oxidative Stress and TGF-β1 Signaling.The real culprit behind diabetic nephropathy: impaired renal autoregulation?Frequency of Type-2 diabetes mellitus in Nephropathic patients and comparison of mean magnesium levels in Nephropathic patients with and without Type-2 diabetes mellitus.Effect of Canagliflozin on Urinary Albumin Excretion in Japanese Patients with Type 2 Diabetes Mellitus and Microalbuminuria: A Pilot StudyAlbuminuria Increases All-Cause Mortality in Japanese Patients with Type 2 Diabetes MellitusDiabetic nephropathy and hypertension in diabetes patients of sub-Saharan countries: a systematic review and meta-analysis
P2860
The Prevalence and Management of Diabetic Nephropathy in Asia
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The Prevalence and Management of Diabetic Nephropathy in Asia
@ast
The Prevalence and Management of Diabetic Nephropathy in Asia
@en
The Prevalence and Management of Diabetic Nephropathy in Asia
@nl
type
label
The Prevalence and Management of Diabetic Nephropathy in Asia
@ast
The Prevalence and Management of Diabetic Nephropathy in Asia
@en
The Prevalence and Management of Diabetic Nephropathy in Asia
@nl
prefLabel
The Prevalence and Management of Diabetic Nephropathy in Asia
@ast
The Prevalence and Management of Diabetic Nephropathy in Asia
@en
The Prevalence and Management of Diabetic Nephropathy in Asia
@nl
P2860
P356
P1476
The Prevalence and Management of Diabetic Nephropathy in Asia
@en
P2093
Tomohito Gohda
Yasuhiko Tomino
P2860
P356
10.1159/000381757
P407
P577
2015-05-01T00:00:00Z